Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ATI vs GSK✓SelectedUSD · GSKATI vs GSK performance historyLatest closeAs of-5.01%11/20
Stock and ETF performance explorer

ATI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+926.7%
GSK return
+40.7%
Excess return
+886.0%
Maximum drawdown
-38.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.0%-0.1%-4.9%-5.0%
7D-9.6%-5.3%-4.2%-8.6%
30D-8.4%-3.7%-4.7%-7.8%
3M-20.8%-7.3%-13.6%-19.8%
6M+7.7%-4.2%+12.0%+8.0%
YTD+44.3%+0.9%+43.4%+43.6%
1Y+74.7%+7.3%+67.4%+71.6%
3Y+271.4%+52.7%+218.6%+229.1%
All+926.7%+40.7%+886.0%+775.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling